Oxidative stress in association with risk factors for the occurrence and development of age-related macular degeneration;Oksidativni stres u sklopu faktora rizika od nastanka i razvoja senilne degeneracije makule

Vojnosanitetski Pregled

Volumn 65, Issue 4, 2008, Pages 313-318

  Žorić, Lepša ^a,e   Kosanović Jaković, Natalija ^c   Čolak, Emina ^d   Radosavljević, Aleksandra ^c   Jakšić, Vesna ^a   Stević, Snežana ^b  

^a Medicinski Fakultet   (Macedonia)

^b Institut za Farmakologiju   (Macedonia)

^c Institut za O ne Bolesti   (Macedonia)

^d Institut za Medicinsku Biohemiju   (Yugoslavia)

^e NONE   (Serbia)

Author keywords

Aging; Macular degenration; Oxidative stress; Retinal degeneration; Risk factors

Indexed keywords

LIPOFUSCIN; VASCULOTROPIN;

HUMAN; OXIDATIVE STRESS; PIGMENT EPITHELIUM; RETINA; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; AGED; AGING; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA MACULA DEGENERATION;

AGED; AGING; HUMANS; MACULAR DEGENERATION; OXIDATIVE STRESS; RETINA; RISK FACTORS;

EID: 45749110680     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP0804313Z     Document Type: Review

References (93)

1. Weale RA. Senescent vision: is it all the fault of the lens? Eye 1987; 1(Pt 2): 217-221
2. McGrath D, Morrison JD. The effects of aging on the optical quality of human eye. J Exp Physiol 1983; 343: 81-89
3. Morrison JD, McGrath C. Assessment of the optical contributions to the age-related deterioration in vision. Q J Exp Physiol 1985; 70(2): 249-269 (Pubitemid 15105520)
4. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 1988; 128(4): 700-710 (Pubitemid 18245009)
5. Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122(4): 564-572 (Pubitemid 38456293)
6. Žorić L, Jovanović P. Oxidation stress in the ocular diseases pathogenesis. Niš: Sven; 2006. (Serbian)
7. Lai YL, Masuda K, Mangum MD, Lug R, Macrae DW, Fletcher G, et al. Subretinal displacement of photoreceptor nuclei in human retina. Exp Eye Res 1982; 34(2): 219-228 (Pubitemid 12184906)
8. Marshall J, Grindle J, Ansell PL, Borwein B. Convolution in human rods: an ageing process. Br J Ophthalmol 1979; 63(3): 181-187 (Pubitemid 9123088)
9. Tucker GS. Refractile bodies in the inner segments of cones in the aging human retina. Invest Ophthalmol Vis Sci 1986; 27(5): 708-715 (Pubitemid 16080487)
10. Repka MX, Quigley HA. The effect of age on normal human optic nerve fiber number and diameter. Ophthalmology 1989; 96(1): 26-32. (Pubitemid 19041323)
11. Vrabec F. Age changes of the human optic nerve head. A neurohistologic study. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1977; 202(3): 231-236
12. Henderson G, Tomlinson BE, Gibson PH. Cell counts in human cerebral cortex in normal adults throughout life using an image analysing computer. J Neurol Sci 1980; 46(1): 113-136 (Pubitemid 10153819)
13. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987; 31(5): 291-306. (Pubitemid 17076515)
14. Feeney-Burns L, Burns RP, Gao CL. Age-related macular changes in humans over 90 years old. Am J Ophthalmol 1990; 109(3): 265-278 (Pubitemid 20078944)
15. Schraermeyer U, Heimann K. Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Res 1999; 12(4): 219-236 (Pubitemid 129686284)
16. Weiter JJ, Delori FC, Wing GL, Fitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 1986; 27(2): 145-152 (Pubitemid 16129780)
17. Burns RP, Feeney-Burns L. Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc 1980; 78: 206-225 (Pubitemid 11035013)
18. Weiter JJ, Delori FC, Wing GL, Fitch KA. Relationship of senile macular degeneration to ocular pigmentation. Am J Ophthalmol 1985; 99(2): 185-187 (Pubitemid 15119580)
19. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res 2000; 19(2): 205-221
20. Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis 1999; 5: 25.
21. Holz FG, Bellman C, Staudt S, Schütt F, Völcker HE. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 2001; 42(5): 1051-1056 (Pubitemid 32289803)
22. Löffler KU, Lee WR. Basal linear deposit in the human macula. Graefes Arch Clin Exp Ophthalmol 1986; 224(6): 493-501.
23. Seddon JM, Chen CA. The epidemiology of age-related macular degeneration. Int Ophthalmol Clin 2004; 44(4): 17-39. (Pubitemid 39392076)
24. Mitchell P, Foran S. Age-Related Eye Disease Study severity scale and simplified severity scale for age-related macular degeneration. Arch Ophthalmol 2005; 123(11): 1598-1599 (Pubitemid 41626699)
25. Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 2005; 123(11): 1484-1498 (Pubitemid 41626684)
26. Bressler SB, Maguire MG, Bressler NM, Fine SL. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol 1990; 108(10): 1442-1447 (Pubitemid 20344701)
27. Kosanović-Jaković N, Mitrović M, Jovanović S, Ivanković Lj. Age-related disciform macular degenration-indications for laser photocoagulation treatment. Medicinska istraživanja 1996; 29: 22-26 (Serbian)
28. Milenković S, Kosanović-Jaković N, editors Macula. Napredak, AranCrossed d signelovac: 2001. (Serbian)
29. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004; 122(4): 598-614. (Pubitemid 38456297)
30. Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology 1985; 92(5): 615-627 (Pubitemid 15060973)
31. Penfold PL, Provis JM, Billson FA. Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol 1987; 225(1): 70-76
32. Ryan SJ. The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc 1979; 77: 707-745 (Pubitemid 10072828)
33. Congdon N, O'Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122(4): 477-485 (Pubitemid 38456282)
34. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 1999; 106(6): 1056-1065 (Pubitemid 30191505)
35. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308(5720): 385-389 (Pubitemid 40530070)
36. Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A, Postel EA, et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 2006; 47(1): 329-335 (Pubitemid 46780832)
37. Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol 1983; 118(2): 213-227
38. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986; 93(5): 552-558 (Pubitemid 16086704)
39. West SK, Rosenthal FS, Bressler NM, Bressler SB, Munoz B, Fine SL, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989; 107(6): 875-879 (Pubitemid 19166363)
40. Taylor HR, West S, Muñoz B, Rosenthal FS, Bressler SB, Bressler NM. The long-term effects of visible light on the eye. Arch Ophthalmol 1992; 110(1): 99-104.
41. Young RW. Solar radiation and age-related macular degeneration. Surv Ophthalmol 1988; 32(4): 252-269 (Pubitemid 18066235)
42. Vidaurri JS, Pe'er J, Halfon ST, Halperin G, Zauberman H. Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica 1984; 188(4): 243-247 (Pubitemid 14082676)
43. Landolfo V, Albini L, DeSimone S. Senile macular degeneration and alteration of the metabolism of the lipids. Ophthalmologica 1978; 177(5): 248-253 (Pubitemid 9111433)
44. Sperduto RD, Hiller R, Seigel D. Lens opacities and senile maculopathy. Arch Ophthalmol 1981; 99(6): 1004-1008 (Pubitemid 11070418)
45. Liu IY, White L, LaCroix AZ. The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health 1989; 79(6): 765-769 (Pubitemid 19142919)
46. Zigler JS Jr, Bodaness RS, Gery I, Kinoshita JH. Effects of lipid peroxidation products on the rat lens in organ culture: a possible mechanism of cataract initiation in retinal degenerative disease. Arch Biochem Biophys 1983; 225(1): 149-156
47. Goosey JD, Tuan WM, Garcia CA. A lipid peroxidative mechanism for posterior subcapsular cataract formation in the rabbit: a possible model for cataract formation in tapetoretinal diseases. Invest Ophthalmol Vis Sci 1984; 25(5): 608-612 (Pubitemid 14149156)
48. Babizhayev MA, Deyev AI. Lens opacity induced by lipid peroxidation products as a model of cataract associated with retinal disease. Biochim Biophys Acta 1989; 1004(1): 124-133 (Pubitemid 19178623)
49. Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. The Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology 1998; 105(8): 1364-1372
50. Erie JC, Good JA, Butz JA, Hodge DO, Pulido JS. Urinary cadmium and age-related macular degeneration. Am J Ophthalmol 2007; 144(3): 414-418. (Pubitemid 47331401)
51. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291(6): 704-710 (Pubitemid 38543790)
52. Killingsworth MC, Sarks JP, Sarks SH. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 1990; 4(Pt 4): 613-621 (Pubitemid 20376823)
53. Brantley MA Jr, Edelstein SL, King JM, Apte RS, Kymes SM, Shiels A. Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration. Am J Ophthalmol 2007; 144(3): 404-408 (Pubitemid 47331399)
54. Uka J, Tamura H, Kobayashi T, Yamane K, Kawakami H, Minamoto A, et al. No association of complement factor H gene polymorphism and age-related macular degeneration in the Japanese population. Retina 2006; 26(9): 985-987 (Pubitemid 44973215)
55. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45(2): 115-134 (Pubitemid 30738400)
56. De La Paz M, Anderson RE. Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci 1992; 33(13): 3497-3499 (Pubitemid 23001363)
57. Nicolas MG, Fujiki K, Murayama K, Suzuki MT, Shindo N, Hotta Y, et al. Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress. Exp Eye Res 1996; 62(4): 399-408.
58. Evereklioglu C, Er H, Doganay S, Cekmen M, Turkoz Y, Otlu B, et al. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol 2003; 106(2): 129-136 (Pubitemid 36355954)
59. Žorić L. Parameters of oxidative stress in the lens, aqueous humor and blood in patients with diabetes and senile cataracts. Srp Arh Celok Lek 2003; 131(3-4): 137-142 (Serbian)
60. Čolak E, Majkić-Singh N, Stanković S, Srećković-Dimitrijević V, Crossed D signorCrossed d signević PB, Lalić K, et al. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med 2005; 37(8): 613-620
61. Nowak M, Swietochowska E, Wielkoszyński T, Marek B, Karpe J, Górski J, et al. Changes in blood antioxidants and several lipid peroxidation products in women with age-related macular degeneration. Eur J Ophthalmol 2003; 13(3): 281-286 (Pubitemid 37279511)
62. Ohno-Matsui K. Molecular mechanism for choroidal neovascularization in age-related macular degeneration. Nippon Ganka Gakkai Zasshi 2003; 107(11): 657-673 (Japanese)
63. Kim I, Ryan AM, Rohan R, Amano S, Agular S, Miller JW, et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci 1999; 40(9): 2115-2121
64. Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PT. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 1997; 81(2): 154-162 (Pubitemid 27092496)
65. Wells JA, Murthy R, Chibber R, Nunn A, Molinatti PA, Kohner EM, et al. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. Br J Ophthalmol 1996; 80(4): 363-366 (Pubitemid 26113591)
66. Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY. Age-related macular degeneration is associated with increased vas cular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 2001; 108(4): 705-710 (Pubitemid 32238466)
67. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis 1999; 5: 32.
68. Moore DJ, Clover GM. The effect of age on the macromolecular permeability of human Bruch's membrane. Invest Ophthalmol Vis Sci 2001; 42(12): 2970-2975 (Pubitemid 33035298)
69. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 2002; 99(23): 14682-14687 (Pubitemid 35334544)
70. Ayalasomayajula SP, Kompella UB. Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells. Eur J Pharmacol 2002; 449(3): 213-220 (Pubitemid 34886477)
71. King A, Gottlieb E, Brooks DG, Murphy MP, Dunaief JL. Mitochondria-derived reactive oxygen species mediate blue light-induced death of retinal pigment epithelial cells. Photochem Photobiol 2004; 79(5): 470-475
72. Muradian K, Schachtschabel DO. The role of apoptosis in aging and age-related disease: update. Z Gerontol Geriatr 2001; 34(6): 441-446 (Pubitemid 34087415)
73. Haddad WM, Coscas G, Soubrane G. Age-related macular degeneration and apoptosis. J Fr Ophtalmol 2003; 26(3): 307-311 (French) (Pubitemid 36722932)
74. Yu J, Wu L, Lin X. Preliminary study of mitochondrial DNA deletions in age-related macular degeneration. Yan Ke Xue Bao 1997; 13(2): 52-55 (Chinese)
75. Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 2003; 76(4): 397-403. (Pubitemid 36299052)
76. Weigel AL, Handa JT, Hjelmeland LM. Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med 2002; 33(10): 1419-1432
77. Boulton M, Marshall J. Effects of increasing numbers of phagocytic inclusions on human retinal pigment epithelial cells in culture: a model for aging. Br J Ophthalmol 1986; 70(11): 808-815 (Pubitemid 17174359)
78. Katz ML, Eldred GE. Retinal light damage reduces autofluorescent pigment deposition in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1989; 30(1): 37-43. (Pubitemid 19039877)
79. Junghans A, Sies H, Stahl W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys 2001; 391(2): 160-164 (Pubitemid 32662257)
80. Sommerburg OG, Siems WG, Hurst JS, Lewis JW, Kliger DS, van Kuijk FJ. Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res 1999; 19(6): 491-495 (Pubitemid 30052875)
81. Packer L. Antioxidant action of carotenoids in vitro and in vivo and protection against oxidation of human low-density lipoproteins. Ann N Y Acad Sci 1993; 691: 48-60. (Pubitemid 24099379)
82. Böhm F, Tinkler JH, Truscott TG. Carotenoids protect against cell membrane damage by the nitrogen dioxide radical. Nat Med 1995; 1(2): 98-99
83. Elsner AE, Burns SA, Weiter JJ. Cone photopigment in older subjects: decreased optical density in early age-related macular degeneration. J Opt Soc Am A Opt Image Sci Vis 2002; 19(1): 215-222
84. Liang FQ, Green L, Wang C, Alssadi R, Godley BF. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp Eye Res 2004; 78(6): 1069-1075 (Pubitemid 38510344)
85. Hardeland R, Coto-Montes A, Poeggeler B. Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol Int 2003; 20(6): 921-962 (Pubitemid 37517510)
86. Li D, Sun F, Wang K. Caloric restriction retards age-related changes in rat retina. Biochem Biophys Res Commun 2003; 309(2): 457-463 (Pubitemid 37025912)
87. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 2003; 121(12): 1728-1737 (Pubitemid 37517440)
88. Fatty diets mean faster AMD progression. Health News 2004; 10(2): 13.
89. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272(18): 1413-1420
90. Roodenburg AJ, Leenen R, van het Hof KH, Weststrate JA, Tijburg LB. Amount of fat in the diet affects bioavailability of lutein esters but not of alpha-carotene, beta-carotene, and vitamin E in humans. Am J Clin Nutr 2000; 71(5): 1187-1193 (Pubitemid 30230567)
91. Simonelli F, Zarrilli F, Mazzeo S, Verde V, Romano N, Savoia M, et al. Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy. Clin Chim Acta 2002; 320(1-2): 111-115 (Pubitemid 34450829)
92. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119(10): 1417-1436 (Pubitemid 32963246)
93. Age-Related Eye Disease Study Research Group. The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. J Nutr 2002; 132(4): 697-702. (Pubitemid 34275068)